FAQ: Izotropic Corporation's $300K Private Placement and Warrant Extension
Summary
What is the main announcement from Izotropic Corporation?
Izotropic announced a non-brokered private placement to raise up to $300,000 by selling 1.2 million units at $0.25 each, and extended the expiry of 2,841,325 warrants issued in September 2023 by one year to September 20, 2026.
How much money is Izotropic trying to raise through the private placement?
The company aims to raise gross proceeds of up to $300,000 through the private placement.
What does each unit in the private placement include?
Each unit includes one common share and one transferable warrant exercisable at $0.50 for three years.
How will the proceeds from the private placement be used?
The proceeds will be used for general working capital purposes.
What is the status of the warrant extension?
The warrant extension remains subject to final approval by the Canadian Securities Exchange (CSE).
What is Izotropic Corporation’s business focus?
Izotropic is a medical device company focused on developing imaging-based products for breast cancer care.
Where can investors find more information about Izotropic Corporation?
More information can be found on the company’s website at izocorp.com and by reviewing its profile on SEDAR at sedarplus.ca.
Where can I find the latest news and updates about Izotropic?
The latest news and updates relating to IZOZF are available in the company’s newsroom at https://ibn.fm/IZOZF.
What is TechMediaWire and how is it related to this announcement?
TechMediaWire is a specialized communications platform that published this announcement and provides distribution services for technology companies, including access to wire solutions, media syndication, and social media distribution.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 181428